Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 09-2025 | 07-2025 | 04-2025 | 01-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 243,497 | 124,304 | 131,615 | 167,288 | 182,326 |
| Marketable Securities | 65,661 | 67,161 | 89,002 | 85,915 | 86,019 |
| Receivables | 7,122 | 2,487 | 1,383 | 7,485 | 11,417 |
| Inventories | 458 | N/A | N/A | N/A | N/A |
| TOTAL | $325,226 | $205,896 | $241,690 | $267,359 | $285,979 |
| Non-Current Assets | |||||
| PPE Net | 3,190 | 2,067 | 1,988 | 1,807 | 1,884 |
| Other Non-Current Assets | 11,515 | 7,542 | 7,092 | 6,827 | 6,953 |
| TOTAL | $14,705 | $9,609 | $9,080 | $8,634 | $8,837 |
| Total Assets | $339,931 | $215,505 | $250,770 | $275,993 | $294,816 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,074 | 5,869 | 4,883 | 5,856 | 5,726 |
| Accrued Expenses | 20,767 | 18,971 | 27,307 | 18,315 | 18,936 |
| Other current liabilities | 3,287 | N/A | N/A | N/A | N/A |
| TOTAL | $45,069 | $38,375 | $45,167 | $25,615 | $26,114 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,512 | 11,413 | 11,000 | N/A | N/A |
| Other Non-Current Liabilities | 277,863 | 136,340 | 110,212 | 105,252 | 104,343 |
| TOTAL | $277,863 | $136,340 | $110,212 | $105,252 | $104,343 |
| Total Liabilities | $322,932 | $174,715 | $155,379 | $130,867 | $130,457 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,546 | 50,523 | N/A | 49,716 | N/A |
| Common Shares | 50 | 50 | 50 | 49 | 49 |
| Retained earnings | -739,098 | -713,266 | -653,170 | -600,946 | -580,184 |
| Other shareholders' equity | -6,729 | -6,387 | -5,214 | -2,208 | -2,418 |
| TOTAL | $16,999 | $40,790 | $95,391 | $145,126 | $164,359 |
| Total Liabilities And Equity | $339,931 | $215,505 | $250,770 | $275,993 | $294,816 |